E. Ozdemir et al., Role of matrix metalloproteinase-9 in the basement membrane destruction ofsuperficial urothelial carcinomas, J UROL, 161(4), 1999, pp. 1359-1363
Purpose: This study was conducted to clarify which matrix metalloproteinase
s (MMPs) play a key role in destruction of the underlying basement membrane
(BM) of superficial urothelial carcinomas. Urine concentrations of MMP-9 a
nd tissue inhibitors of matrix metalloproteinase-l (TIMP-1) were also measu
red.
Materials and Methods: Overexpression of MMP-1, MMP-2 and MMP-9 was analyze
d immunohistochemically in 60 patients with transitional cell carcinomas of
the urothelium (41 were pTa or pis, 19 were pT(1-4)), and compared them wi
th type IV collagen expression in tumor BM. In 33 of them, urine concentrat
ions of MMP-9 and TIMP-1 were measured by one-step sandwich enzyme immunoas
say.
Results: Positive expression of MMP-1, MMP-2 and MMP-9 was found in 53%, 17
%, and 65% of tumors, respectively. Only MMP-9 expression rates were increa
sed with grades and stages (p = 0.03). In pTa and pis tumors, type IV colla
gen expression was reduced in 17 of 26 (65.4%), and it was associated with
positive MMP-9 expression (p = 0.0283). MMP-9 was detected in all urine sam
ples of urothelial cancer patients, while urine TIMP-1 was detectable in 18
of 33 patients. In 16 healthy volunteers, both of them were below detectab
le levels, Balance between urinary MMP-9 and TIMP-1 were particularly kept
in superficial urothelial carcinomas with intact tumor BM. Tumor BM: status
, however, was not associated with urinary MMP-9 or TIMP-1 levels.
Conclusions: These results suggest that MMP-9 plays a key role in the invas
ion step of superficial urothelial carcinomas. Detection of urinary MMP-9 m
ay become a new, non-invasive mean for the diagnosis of urothelial carcinom
as.